Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient (opens in new tab)

A special 79-year-old man has received unparalleled access to Eli Lilly’s obesity drug.Millions of Americans are eagerly awaiting access to retatrutide, a powerful new drug from the pharmaceutical company. But one unidentified person has been able to gain premature access to the drug via the FDA’s “compassionate use” program, STAT reported Tuesday.The FDA program is designed to prioritize access to experimental drugs for patients with grave or life-threatening medical issues. And while the na...